New monoclonal antibodies targeting IL-17 and IL-12/23
Written by: Jonathan Simmons | Last reviewed: September 2013.
1. Reichert JM. Which are the antibodies to watch in 2013? MAbs 2013;5:1-4. 2. Clinicaltrials.gov. 3. Buch MH, Emery P. New therapies in the management of rheumatoid arthritis. Curr Opin Rheumatol 2011;23:245-51. 4. Hueber W, Patel DD, Dryja T, et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2010;2:52ra72. 5. Genovese MC, Durez P, Richards HB, et al. One year efficacy and safety results of a phase II trial of secukinumab in patients with rheumatoid arthritis [Abstract 401]. Presented at the 75th Annual Meeting of the American College of Rheumatology. Chicago, IL; November 4-9, 2011. 6. IL-17 blocker shows promise in arthritis trial. MedPage Today; June 8, 2012.